Survival data for the transplants aged 5 and 6 years were excluded from the analyses because mortality so soon after transplantation was extremely rare.
Miss Bassin is now operating Bassinnova, Inc., which she calls a "rent a‐brain service". Welcome to the transplant age.
The multivariable model for the outcome AKI includes aGVHD status (grade 2-4 vs grade 0-1), SOS, and patient age at transplant (age ≥40 yrs vs age <40 yrs).
Patient characteristics were recorded at transplant assessment and on the day of transplant: age, MELD score, UKELD score, serum sodium, creatinine, bilirubin, albumin, INR.
Females had more symptoms than males on both the MMQ and transplant age of <13 years appeared to result in more cognitive symptoms with the MMQ only.
In contrast, age at transplant, age at relapse, gender, female to male transplant, graft source, recipient CMV serostatus, donor CMV serostatus, acute GvHD, pre-transplant TKI use, DLI, or concurrent DLI with TKI had no impact on post relapse survival.
Other factors included in the analysis but not significant include preparative regimen, cranial irradiation, chronic GVHD, age at transplant, age at study participation, and second transplant (data not shown).
Other factors included in the analysis but are not significant include preparative regimen, cranial irradiation, chronic GVHD, age at transplant, age at study participation, donor type and second transplant (data not shown).
Probability of NODAT = 1/ 1 + e(−fn[ x]) where f[ x] = −2.4684 + 0.5396 (if transplant age ≥50 years) + 0.4914 (if family history of T2DM) + 0.7410 (if steroid maintenance) + 0.7285 (if pretransplant fasting glucose ≥100 mg/dL) + 0.3693 (if pretransplant BMI ≥30 kg/m) + 0.8440 (if pretransplant triglyceride ≥200 mg/dL) + 0.7917 (if gout medicine used pretransplant).
Patients: Fifteen renal transplants (mean age, 13.3 ± 2.8 years) and 35 continuous ambulatory peritoneal dialysis (CAPD) patients (mean age, 12.6 ± 3.0 years) participated.
Mixed-effects linear regression models revealed that participants who reported greater depression and anxiety experienced poorer sleep quality, after covarying for the effects of time since transplant, sex, age, graft type, conditioning regimen, steroid use, and disease status.
